GlassScriptPhysician profile
Sharon K Cox
NPI 1487904702
$2,243.24
in general payments reported to CMS, 2019-2025
35 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $185 · 2021: $26.77 · 2022: $199 · 2023: $259 · 2024: $498 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $275.63 | 2019-2025 | |
| Lilly USA, LLC | $268.84 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $246.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $186.80 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Abbott Laboratories | $165.71 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astellas Pharma US INC | $136.03 | 2019-2023 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.43 | 2019-2023 | |
| Glaxosmithkline, LLC. | $75.27 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $73.91 | 2019-2024 | Breztri, Airsupra |
| Exact Sciences Corporation | $68.92 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $67.71 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.69 | 2019 | |
| Corcept Therapeutics | $44.98 | 2025 | Korlym |
| Hologic Sales and Service, LLC | $43.76 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Philips North America LLC | $38.63 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.30 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $29.37 | 2023 | Bodyguardian |
| Redhill Biopharma INC. | $24.82 | 2020 | |
| Janssen Pharmaceuticals, INC | $24.81 | 2023 | Xarelto |
| Daiichi Sankyo INC. | $24.51 | 2019 | |
| Bausch Health US, LLC | $23.09 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $22.11 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $19.80 | 2025 | Neffy |
| Alexion Pharmaceuticals, INC. | $19.49 | 2022 | |
| Allergan, INC. | $18.58 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.03 | 2025 | Caplyta |
| Sumitomo Pharma America, INC. | $16.74 | 2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $15.86 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.21 | 2021 | |
| Nevro Corp. | $14.43 | 2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.34 | 2019 | |
| Tolmar, INC. | $13.59 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $12.86 | 2022 | |
| Tactile Systems Technology INC | $12.49 | 2019 | |
| Smith+Nephew, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.